Irish reimbursement granted for AbbVie's RINVOQ® (upadacitinib)
AbbVie has announced the availability in Ireland of upadacitinib, an oral, selective and reversible Janus Kinase (JAK) inhibitor, for the treatment of
Stay updated with breaking news from Managed Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbbVie has announced the availability in Ireland of upadacitinib, an oral, selective and reversible Janus Kinase (JAK) inhibitor, for the treatment of
Today only 11% of Marine Protected Areas are inside territorial waters. Most are established offshore, far from the biodiversity-rich territorial seas
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- MedaSystems, a digital health software company, is excited to announce the completion of a $1.5 million pre-seed funding round led by...
/PRNewswire/ -- MedaSystems, a digital health software company, is excited to announce the completion of a $1.5 million pre-seed funding round led by...